We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Treatment for Cancer in Butterfly Disease Set to Start Clinical Trials

News   Mar 08, 2019 | Original story from Jefferson

 
Treatment for Cancer in Butterfly Disease Set to Start Clinical Trials

Recessive dystrophic epidermolysis bullosa (RDEB) is sometimes called “butterfly disease” since patients have skin that is as fragile as the wings of a butterfly. Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

New Immune Cell on the Block During Viral Lung Infections

News

Scientists have identified a novel group of immune cells in the lungs that are associated with the control of inflammation during viral infections, like influenza or possibly coronavirus. This discovery may help to advance the development of therapeutics to treat inflammation-related lung conditions such as bronchitis, influenza and potentially even COVID-19.

READ MORE

Histone Deacetylase May Be a Novel Therapeutic Strategy for Lung Cancer

News

In continued efforts to reduce the mortality rate of non-small cell lung cancer (NSCLC), researchers have demonstrated how targeting the histone deacetylase HDAC11 may be a novel therapeutic strategy for NSCLC.

READ MORE

Study Provides Insights Into the Diagnosis and Treatment of Pediatric Brain Cancer

News

In a recent study published in Autophagy, researchers at Kanazawa University show how abnormalities in a gene called TPR can lead to pediatric brain cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE